Bio-Techne Target Price

Where could TECH trade next? Consensus target price: $73.

Get informed when a big investor buys or sells

+ Follow

Share Price

$72.57

Average Target Price

$73.00

0.6% upside

5 analysts in the last 4 months

High: $73 | Low: $73

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-13	Wells Fargo	$73	0.6% upside
2026-06-26	StephensSteven Etoch	$73	0.6% upside
2026-06-26	Robert W. BairdCatherine Ramsey Schulte	$73	0.6% upside
2026-06-26	Deutsche BankJustin Bowers	$73	0.6% upside
2026-06-25	Leerink PartnersMarket Perform	$73	0.6% upside
2026-06-11	Piper Sandler	$65	10.4% downside
2026-05-14	RBC Capital	$62	14.6% downside
2026-05-07	Evercore ISIDaniel Markowitz	$50	31.1% downside
2026-05-07	Stifel Nicolaus	$50	31.1% downside
2026-05-07	Robert W. Baird	$49	32.5% downside
2026-02-05	Stifel Nicolaus	$65	10.4% downside
2026-02-05	UBS	$79	8.9% upside
2026-02-05	Robert W. Baird	$70	3.5% downside
2026-01-05	Evercore ISI	$62	14.6% downside
2025-12-12	Deutsche BankJustin Bowers	$72	0.8% downside
2025-11-20	Argus Research	$68	6.3% downside
2025-11-06	Evercore ISI	$68	6.3% downside
2025-09-02	RBC CapitalConor McNamara	$73	0.6% upside
2025-03-17	Evercore ISI	$75	3.3% upside
2024-10-31	Robert W. BairdCatherine Schulte	$84	15.8% upside
2024-10-30	KeyBancPaul Knight	$80	10.2% upside
2024-08-16	ScotiabankSung Ji Nam	$83	14.4% upside
2022-12-14	Deutsche Bank	$100	37.8% upside
2022-12-12	Citigroup	$100	37.8% upside
2022-12-07	RBC Capital	$89	22.6% upside
2022-12-05	Stephens	$105	44.7% upside
2022-05-05	KeyBancPaul Knight	$125	72.2% upside
2022-04-25	Wells Fargo	$92.5	27.5% upside
2021-05-06	CitigroupPatrick B Donnelly	$106.25	46.4% upside

Bio-Techne (TECH) FAQ

Bio-Techne posts a target price of $73. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $73 for TECH means covering analysts, on average, see the stock 0.6% upside of $72.57 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for TECH's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bio-Techne's other metric pages and overview cover the third.

Judging Bio-Techne against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $73 here, then scan peer and history charts to see if the gap is persistent.